Multiple Hormones Regulate Angiotensinogen Messenger Ribonucleic Acid Levels in a Rat Hepatoma Cell Line
- 1 August 1987
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 121 (2) , 513-519
- https://doi.org/10.1210/endo-121-2-513
Abstract
Angiotensinogen is regulated by both hormones and changes in cardiovascular and electrolyte status. We have used the Reuber (H4IIE) rat hepatoma cell line to study the regulation of angiotensinogen mRNA levels by dexamethasone, aldosterone, L-T3, and 17 .beta.-estradiol. Using the AccI (1097 basepairs) fragment of our angiotensinogen cDNA clone, we have studied, by Northern and slot blot analysis, the accumulation of angiotensinogen mRNA in this cell culture system. Angiotensinogen mRNA of approximately 1800 bases was identified in these cells. It was identical in size to angiotensinogen mRNA from rat liver. Cells grown in medium containing serum depleted of thyroid and steroid hormones for up to 72 h showed a progressive decrease in angiotensinogen mRNA. Dexamethasone treatment resulted in a time- and dose-dependent increase in angiotensinogen mRNA. The half-maximal response occurred at 10-9 M dexamethasone, with a maximal response of approximately 4-fold (serum-free conditions). Aldosterone induced a dose-dependent increase in mRNA. Half-maximal levels were obtained at 5 .times. 10-8 M. Competition studies using the glucocorticoid antagonist RU38486 (Roussel-UCLAF) confirmed that dexamethasone was acting through the glucocorticoid receptor and suggested that aldosterone was acting through the same receptor. L-T3 treatment caused a dose and time-dependent increase in angiotensinogen mRNA levels. The half-maximal response occurred at 5 .times. 10-8 M, and the maximal response was a 2-fold increase. Combined treatment with dexamethasone and L-T3 triiodothyronine resulted in a synergistic increase in angiotensinogen mRNA levels. 17.beta.-Estradiol failed to elicit a change in angiotensinogen mRNA levels consistent with the observation that these cells lack estrogen receptors. Our results indicate that hepatic angiotensinogen mRNA levels are regulated in a complex fashion by several hormones. These cells provide a useful system for studying the hormonal regulation of the angiotensinogen gene.This publication has 20 references indexed in Scilit:
- Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin.Journal of Biological Chemistry, 1984
- The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in ManJournal of Clinical Endocrinology & Metabolism, 1984
- Angiotensinogen production by rat hepatoma cells in culture and analysis of its regulation by techniques of somatic cell genetics.The Journal of cell biology, 1983
- Cloning and sequence analysis of cDNA for rat angiotensinogen.Proceedings of the National Academy of Sciences, 1983
- Vitellogenin gene expression in male xenopus hepatocytes during primary and secondary stimulation with estrogen in cell culturesCell, 1981
- EFFECTS OF INSULIN AND GLUCAGON ON PRODUCTION OF RENIN SUBSTRATE BY THE ISOLATED RAT LIVERJournal of Endocrinology, 1980
- Oral contraceptives—possible mediation of side effects via an estrogen receptor in liverBiochemical Pharmacology, 1978
- Renin-Renin Substrate Kinetic Constants in the Plasma of Normal and Estrogen-Treated HumansJournal of Clinical Endocrinology & Metabolism, 1977
- Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.Proceedings of the National Academy of Sciences, 1977
- Renin substrate in plasma under various experimental conditions in the ratAmerican Journal of Physiology-Legacy Content, 1967